Inhibitor Therapeutics (INTI) Non Operating Interest Expenses (2013 - 2022)
Inhibitor Therapeutics' (INTI) quarterly Non Operating Interest Expenses came in at $3356.0 in Q4 2022, down 30.11% on a YoY basis from $4802.0 in Q4 2021, and down 56.44% quarter-over-quarter from $7705.0 in Q3 2022.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Non Operating Interest Expenses (2013 - 2022) Analysis & Trends
Inhibitor Therapeutics (INTI) has reported Non Operating Interest Expenses for 4 consecutive years, with $3356.0 the latest figure, recorded in Q4 2022.
- For the quarter ending Q4 2022, Non Operating Interest Expenses fell 30.11% year-over-year to $3356.0; the trailing twelve-month figure through Dec 2022 stood at $23234.0 (up 56.59% YoY), and the FY2022 full-year result was $23234.0, up 56.59% from the prior year.
- Non Operating Interest Expenses eased to $3356.0 in Q4 2022 per INTI's latest filing, from $7705.0 in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $7705.0 in Q3 2022 and bottomed at $1685.0 in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -333.60 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 23.78 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 582,000.00 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 2.90 Mn |
| 10 | Inhibitor Therapeutics | 12.17 Mn | 12.17 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 3,356.00 |
| Sep 30, 2022 | 7,705.00 |
| Jun 30, 2022 | 6,763.00 |
| Mar 31, 2022 | 5,410.00 |
| Dec 31, 2021 | 4,802.00 |
| Sep 30, 2021 | 4,803.00 |
| Jun 30, 2021 | 3,547.00 |
| Mar 31, 2021 | 1,685.00 |
| Dec 31, 2014 | 950.00 |
| Sep 30, 2014 | 1,979.00 |
| Jun 30, 2014 | 24,994.00 |
| Mar 31, 2014 | 9,558.00 |
| Jun 30, 2013 | 30,000.00 |